Nuage Therapeutics

About:

Nuage Therapeutics engages in developing drugs which target proteins in disordered regions for challenging indications faced by patients.

Website: https://www.nuagetx.com/

Top Investors: Asabys Partners, Sofinnova Partners, Centre for the Development of Industrial Technology (CDTI), BStartup

Description:

Nuage Therapeutics is a pharmaceutical company which utilizes chemical biology and biomolecular condensation to develop selective drugs that target proteins with disordered regions for challenging indications to improve patient’s life. The focus of the medication is to enhance selective inhibitors of intrinsically disordered proteins involved in challenging indications in order to meet unmet medical needs.

Total Funding Amount:

12M EUR

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2021-01-01

Founders:

Judit Anido Folgueira

Number of Employees:

1-10

Last Funding Date:

2023-03-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai